Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2006

01-11-2006 | Epidemiology

Genetic Polymorphisms of eNOS, Hormone Receptor Status, and Survival of Breast Cancer

Authors: Ji-Yeob Choi, Kyoung-Mu Lee, Dong-Young Noh, Sei-Hyun Ahn, Jong-Eun Lee, Wonshik Han, In-Jin Jang, Sang-Goo Shin, Keun-Young Yoo, Richard B Hayes, Daehee Kang

Published in: Breast Cancer Research and Treatment | Issue 2/2006

Login to get access
Metadata
Title
Genetic Polymorphisms of eNOS, Hormone Receptor Status, and Survival of Breast Cancer
Authors
Ji-Yeob Choi
Kyoung-Mu Lee
Dong-Young Noh
Sei-Hyun Ahn
Jong-Eun Lee
Wonshik Han
In-Jin Jang
Sang-Goo Shin
Keun-Young Yoo
Richard B Hayes
Daehee Kang
Publication date
01-11-2006
Published in
Breast Cancer Research and Treatment / Issue 2/2006
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9245-5

Other articles of this Issue 2/2006

Breast Cancer Research and Treatment 2/2006 Go to the issue

Clinical Trial

Association of GSTP1 CpG Islands Hypermethylation with Poor Prognosis in Human Breast Cancers

Pre-clinical study

E-cadherin Immunohistochemical Expression as a Prognostic Factor in Infiltrating Ductal Carcinoma of the Breast: a Systematic Review and Meta-Analysis

Epidemiology

Infertility, Ovulation Induction Treatments and the Incidence of Breast Cancer—a Historical Prospective Cohort of Israeli Women

Clinical Trial

Advanced breast cancer: anti-progressive immunotherapy using a thermostable autologous hemoderivative

Clinical trial

Economic Analysis of Psychosocial Group Therapy in Women with Metastatic Breast Cancer

Preclinical Study

Rab11a Differentially Modulates Epidermal Growth Factor-induced Proliferation and Motility in Immortal Breast Cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits